Plasmid DNA For Cell & Gene Therapy: It All Starts Here

Critical starting materials, such as plasmid DNA, play a pivotal role in advancing cell and gene therapy, regenerative medicine, and vaccine development. Ensuring their quality and consistency is vital for achieving long-term clinical success.

Watch the informative webinar below featuring Matt Howard, Vice President of Manufacturing, and Tyler Kozisek, Ph.D., Senior Scientist in R&D, who will delve into the strategic importance of partnering with a manufacturing expert to support your therapy’s journey from research to clinical success.

The session will explore how tailored manufacturing solutions can enhance program outcomes, leverage cutting-edge technologies for research and discovery, and optimize preclinical applications. Following the presentations, a live panel session will provide an opportunity to address your specific questions. Don’t miss this chance to gain valuable insights and strategies to maximize the success of your therapeutic programs.